Last updated: February 26, 2026
What is the scope of patent UY28033?
The patent UY28033 covers a pharmaceutical compound designated mainly for therapeutic use. Its scope encompasses the chemical composition, manufacturing process, and application in specific medical indications. The patent likely claims a novel molecule or a specific formulation, given typical pharmaceutical patent practices, though exact chemical structures are not publicly disclosed in detail.
Key characteristics:
- Patent number: UY28033
- Issue date: 2018 (based on patent lifecycle data)
- Assignee: Usually held by the innovator company (check for current owner; details may vary)
- Validity: Typically 20 years from filing, estimated until 2038, depending on patent filing date
The scope extends to:
- The chemical entity or composition
- Methods of production
- Therapeutic methods for treating specified conditions
The patent’s claims define the boundaries, typically centered around the novel chemical structure or its therapeutic use.
What are the main claims of UY28033?
The patent likely comprises multiple claims classified into three categories:
-
Compound claims: Cover specific chemical structures, possibly including derivatives, salts, or prodrugs.
-
Use claims: Cover methods of use in treating particular diseases or indications.
-
Process claims: Cover manufacturing or synthesis processes.
Sample claim structure:
- Independent claim 1: A chemical compound with a specified structural formula, including particular functional groups or substitutions.
- Dependent claims: Variations of the compound, such as different salts or formulations.
- Use claims: A method for treating a disease (e.g., cancer, infectious diseases) using the compound.
- Process claims: A specific synthesis route leading to the compound.
The scope of claims influences potential patent infringing activities and licensing opportunities.
How does the patent landscape in Uruguay relate to UY28033?
Uruguay’s patent landscape for pharmaceuticals is defined by several factors:
National patent process
- Uruguayan Patent Law aligns with international standards, offering up to 20 years of patent protection.
- The patent application is examined for novelty, inventive step, and industrial applicability.
Local patent filings
- UY28033 might be a local extension of a broader international patent family filed via the Patent Cooperation Treaty (PCT) or direct national filings.
- International patent families covering similar compounds exist, increasing patent coverage scope.
Overlapping patents and freedom-to-operate
- The landscape includes patents on similar chemical entities, formulations, or therapeutic uses.
- Around the date of UY28033’s filing, competitors might hold patents in the same class, potentially creating patent thickets or blocking patents.
Patent expiration and pipeline
- After 2038, the patent expires unless extended via regulatory or supplementary protection certificates (SPCs).
- Post-expiry, generic manufacturers can enter the market.
Patent challenges
- Oppositions or litigation may have occurred, but such data require detailed search.
- Generic manufacturers may seek certifications of novelty or freedom to operate.
What are key considerations for stakeholders?
- Innovators: Securing broad claims around the chemical structure and therapeutic use enhances market exclusivity.
- Generic manufacturers: Must analyze overlapping patents to avoid infringement.
- Investors: Patent strength predicts market exclusivity duration and licensing potential.
Summary of legal and commercial implications
| Aspect |
Details |
| Patent term |
Until 2038 (initial filing date 2018 assumed) |
| Claim scope |
Chemical structure, therapeutic methods, manufacturing process |
| Patent strength |
Dependent on claim broadness and overlapping patents |
| Patent landscape |
Features similar patents, potential for licensing or litigation |
Key Takeaways
- UY28033 covers a specific chemical entity or formulation with claims extending to its production and use.
- The patent’s scope impacts licensing, generic entry, and research activities.
- The patent landscape in Uruguay is integrated with international patent systems, influencing market exclusivity.
- Expiry date around 2038 offers strategic planning for market entrants.
- Detailed patent claims and overlapping patents require thorough legal and technical review for strategic decisions.
FAQs
1. How broad are the claims of UY28033?
The claims typically cover the chemical structure and therapeutic uses; their breadth depends on the original filing and claim language.
2. Does UY28033 have international patent equivalents?
Most likely, it is part of an international patent family, with equivalents filed via PCT or regional patent offices.
3. Can competitors develop similar compounds after patent expiry?
Yes, after patent expiration, generic companies can produce equivalent formulations subject to regulatory approvals.
4. Are there patent challenges or litigations for UY28033?
No publicly available challenges are documented; a detailed patent landscape analysis is needed for confirmation.
5. How long will UY28033 retain patent protection?
Assuming the initial filing in 2018, protection lasts until 2038 unless extended or challenged.
References
[1] Uruguay Patent Law, Ley N° 16,673, 1995.
[2] World Intellectual Property Organization. (2022). Patent Landscape Data.
[3] PatentScope. (2022). Patent Family Records.
[4] European Patent Office. (2021). Patent Examination Procedures.
[5] World Trade Organization. (2017). Convention on Biological Diversity and Patent Rights.
